Position in ORGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$89,685
+$24,148 QoQ
Shares Held
37,842
+199.1% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OXFORD ASSET MANAGEMENT LLP holds $1,301,914 across 6 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
8,666 | $355,565 | |
| 2 | ZTS |
Zoetis Inc.
|
4,852 | $348,664 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
432 | $234,070 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
17,514 | $175,140 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
25,548 | $125,951 | |
| 6 | CRON |
Cronos Group Inc.
|
22,491 | $62,524 |
All Filings in ORGO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $89,685 | 37,842 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $65,537 | 12,652 | Shares | Sole | 2026-02-17 | |
| 2024-03-31 | $64,272 | 22,631 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||